FRIDAY, Jan. 4, 2019 — Patients with hypertension with progression
Read moreRisk for MCI Up With Progressive Cerebral Small Vessel Disease
Home »
Eisai and Biogen Present Detailed Results From Phase II Clinical Study of Elenbecestat in MCI and Mild to Moderate Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2018
TOKYO and CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) —
Read more